200 related articles for article (PubMed ID: 28460603)
1. Prevalence and patterns of antidepressant switching amongst primary care patients in the UK.
Mars B; Heron J; Gunnell D; Martin RM; Thomas KH; Kessler D
J Psychopharmacol; 2017 May; 31(5):553-560. PubMed ID: 28460603
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
[TBL] [Abstract][Full Text] [Related]
3. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study.
Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J
PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803
[TBL] [Abstract][Full Text] [Related]
4. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.
Coupland CA; Dhiman P; Barton G; Morriss R; Arthur A; Sach T; Hippisley-Cox J
Health Technol Assess; 2011 Aug; 15(28):1-202, iii-iv. PubMed ID: 21810375
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink.
Iwagami M; Tomlinson LA; Mansfield KE; McDonald HI; Smeeth L; Nitsch D
Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):792-801. PubMed ID: 28397412
[TBL] [Abstract][Full Text] [Related]
6. One-year costs of second-line therapies for depression.
Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151
[TBL] [Abstract][Full Text] [Related]
7. Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study.
Bauer M; Monz BU; Montejo AL; Quail D; Dantchev N; Demyttenaere K; Garcia-Cebrian A; Grassi L; Perahia DG; Reed C; Tylee A
Eur Psychiatry; 2008 Jan; 23(1):66-73. PubMed ID: 18164600
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW
Value Health; 2001; 4(5):362-9. PubMed ID: 11705126
[TBL] [Abstract][Full Text] [Related]
10. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines.
Dunn RL; Donoghue JM; Ozminkowski RJ; Stephenson D; Hylan TR
J Psychopharmacol; 1999; 13(2):136-43. PubMed ID: 10475718
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant switching patterns in the elderly.
Gadzhanova S; Roughead EE; Pont LG
Int Psychogeriatr; 2018 Sep; 30(9):1365-1374. PubMed ID: 29380718
[TBL] [Abstract][Full Text] [Related]
14. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP;
Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care.
Sleath BL; Rubin RH; Huston SA
Ann Pharmacother; 2001 Apr; 35(4):419-23. PubMed ID: 11302403
[TBL] [Abstract][Full Text] [Related]
16. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
17. Sociological influences on antidepressant prescribing.
Sleath B; Shih YC
Soc Sci Med; 2003 Mar; 56(6):1335-44. PubMed ID: 12600369
[TBL] [Abstract][Full Text] [Related]
18. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants.
Martin RM; Hilton SR; Kerry SM; Richards NM
BMJ; 1997 Mar; 314(7081):646-51. PubMed ID: 9066479
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant use and risk of adverse outcomes in older people: population based cohort study.
Coupland C; Dhiman P; Morriss R; Arthur A; Barton G; Hippisley-Cox J
BMJ; 2011 Aug; 343():d4551. PubMed ID: 21810886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
